Marine Perrier

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Mathias Brügel · 5 shared papers, 2023–2025 · strength 0.94
   • Paper Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic can… DOI 10.1038/s41430-025-01566-5↗
   • Paper Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and… DOI 10.1002/ueg2.12602↗
   • Paper Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pan… DOI 10.1016/j.pan.2023.03.005↗
2. Olivier Bouché · 5 shared papers, 2023–2025 · strength 0.94
   • Paper Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic can… DOI 10.1038/s41430-025-01566-5↗
   • Paper Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and… DOI 10.1002/ueg2.12602↗
   • Paper Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pan… DOI 10.1016/j.pan.2023.03.005↗
3. Florian Slimano · 3 shared papers, 2023–2025 · strength 0.59
   • Paper Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic can… DOI 10.1038/s41430-025-01566-5↗
   • Paper Association of palliative care management and survival after chemotherapy discontinuation in patients with advanced pan… DOI 10.1016/j.pan.2023.03.005↗
   • Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791↗
4. Éric François · 1 shared paper, 2025 · strength 0.22
   • Paper Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic can… DOI 10.1038/s41430-025-01566-5↗
5. Tullio Piardi · 1 shared paper, 2024 · strength 0.20
   • Paper Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and… DOI 10.1002/ueg2.12602↗
6. Antoine Le Bozec · 1 shared paper, 2023 · strength 0.18
   • Paper Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective… DOI 10.3389/fphar.2023.1137791↗
7. Anthony Turpin · 1 shared paper, 2023 · strength 0.16
   • Paper Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre … DOI 10.1016/j.pan.2023.06.010↗
8. Stéphanie Truant · 1 shared paper, 2023 · strength 0.16
   • Paper Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre … DOI 10.1016/j.pan.2023.06.010↗
9. Camille Evrard · 1 shared paper, 2023 · strength 0.16
   • Paper Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre … DOI 10.1016/j.pan.2023.06.010↗
10. Nicolas Williet · 1 shared paper, 2023 · strength 0.16
    • Paper Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre … DOI 10.1016/j.pan.2023.06.010↗
11. David Tougeron · 1 shared paper, 2023 · strength 0.16
    • Paper Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre … DOI 10.1016/j.pan.2023.06.010↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.